nodes	percent_of_prediction	percent_of_DWPC	metapath
Vapreotide—TACR1—G alpha (q) signalling events—MGLL—osteoporosis	0.0198	0.0198	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.0194	0.0194	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—MGLL—osteoporosis	0.0177	0.0177	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CALCR—osteoporosis	0.0173	0.0173	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—PTH1R—osteoporosis	0.0173	0.0173	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—PTH1R—osteoporosis	0.016	0.016	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CALCR—osteoporosis	0.016	0.016	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.0153	0.0153	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—CNR2—osteoporosis	0.0146	0.0146	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.0136	0.0136	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—CNR2—osteoporosis	0.0135	0.0135	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—ESR2—osteoporosis	0.0135	0.0135	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—PTH1R—osteoporosis	0.0126	0.0126	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CALCR—osteoporosis	0.0126	0.0126	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.0125	0.0125	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.0116	0.0116	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.0107	0.0107	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—ESR2—osteoporosis	0.0106	0.0106	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CALCR—osteoporosis	0.00978	0.00978	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PTH1R—osteoporosis	0.00978	0.00978	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—PTH—osteoporosis	0.00909	0.00909	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PTH1R—osteoporosis	0.00903	0.00903	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CALCR—osteoporosis	0.00903	0.00903	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PTH1R—osteoporosis	0.00888	0.00888	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CALCR—osteoporosis	0.00888	0.00888	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CNR2—osteoporosis	0.00886	0.00886	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.00845	0.00845	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—LEP—osteoporosis	0.00841	0.00841	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—PTH—osteoporosis	0.00839	0.00839	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—WNT1—osteoporosis	0.00833	0.00833	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PTH1R—osteoporosis	0.0082	0.0082	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CALCR—osteoporosis	0.0082	0.0082	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CNR2—osteoporosis	0.00818	0.00818	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—ADCY5—osteoporosis	0.00779	0.00779	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—MGLL—osteoporosis	0.00777	0.00777	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—WNT1—osteoporosis	0.00769	0.00769	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—PTHLH—osteoporosis	0.00753	0.00753	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—ADCY5—osteoporosis	0.00719	0.00719	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—MGLL—osteoporosis	0.00717	0.00717	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.00716	0.00716	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PTH1R—osteoporosis	0.00711	0.00711	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CALCR—osteoporosis	0.00711	0.00711	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—MGLL—osteoporosis	0.00706	0.00706	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—PTHLH—osteoporosis	0.00695	0.00695	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—POMC—osteoporosis	0.00679	0.00679	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CALCA—osteoporosis	0.00663	0.00663	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—PTH—osteoporosis	0.00661	0.00661	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—MGLL—osteoporosis	0.00651	0.00651	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PTH1R—osteoporosis	0.00645	0.00645	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CALCR—osteoporosis	0.00645	0.00645	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CNR2—osteoporosis	0.00644	0.00644	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—POMC—osteoporosis	0.00627	0.00627	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CALCA—osteoporosis	0.00612	0.00612	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—WNT1—osteoporosis	0.00605	0.00605	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SOST—osteoporosis	0.0058	0.0058	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—POMC—osteoporosis	0.00573	0.00573	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—MGLL—osteoporosis	0.00565	0.00565	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.00564	0.00564	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—PTHLH—osteoporosis	0.00547	0.00547	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.00545	0.00545	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IL1B—osteoporosis	0.00536	0.00536	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SOST—osteoporosis	0.00535	0.00535	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—POMC—osteoporosis	0.00529	0.00529	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PTH1R—osteoporosis	0.00525	0.00525	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CALCR—osteoporosis	0.00525	0.00525	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PTH—osteoporosis	0.00514	0.00514	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—MGLL—osteoporosis	0.00513	0.00513	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CNR2—osteoporosis	0.00501	0.00501	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—POMC—osteoporosis	0.00494	0.00494	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CALCR—osteoporosis	0.00484	0.00484	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PTH1R—osteoporosis	0.00484	0.00484	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CALCA—osteoporosis	0.00482	0.00482	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PTH—osteoporosis	0.00474	0.00474	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PTH—osteoporosis	0.00467	0.00467	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CNR2—osteoporosis	0.00462	0.00462	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00456	0.00456	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CNR2—osteoporosis	0.00455	0.00455	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.00436	0.00436	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PTH—osteoporosis	0.00431	0.00431	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.00429	0.00429	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—WNT1—osteoporosis	0.00427	0.00427	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PTHLH—osteoporosis	0.00426	0.00426	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SOST—osteoporosis	0.00422	0.00422	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00421	0.00421	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CNR2—osteoporosis	0.0042	0.0042	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—MYC—osteoporosis	0.00418	0.00418	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MGLL—osteoporosis	0.00417	0.00417	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TGFB1—osteoporosis	0.00417	0.00417	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—LRP5—osteoporosis	0.00407	0.00407	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—TNF—osteoporosis	0.00395	0.00395	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—WNT1—osteoporosis	0.00395	0.00395	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PTHLH—osteoporosis	0.00393	0.00393	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—LRP6—osteoporosis	0.00389	0.00389	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TNF—osteoporosis	0.00389	0.00389	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PTHLH—osteoporosis	0.00387	0.00387	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MGLL—osteoporosis	0.00385	0.00385	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CALCR—osteoporosis	0.00381	0.00381	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PTH1R—osteoporosis	0.00381	0.00381	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—LRP5—osteoporosis	0.00375	0.00375	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CALCA—osteoporosis	0.00375	0.00375	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PTH—osteoporosis	0.00373	0.00373	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CNR2—osteoporosis	0.00364	0.00364	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—LRP6—osteoporosis	0.00359	0.00359	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PTHLH—osteoporosis	0.00357	0.00357	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—POMC—osteoporosis	0.00347	0.00347	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CALCA—osteoporosis	0.00346	0.00346	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CALCA—osteoporosis	0.0034	0.0034	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PTH—osteoporosis	0.00339	0.00339	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00331	0.00331	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CNR2—osteoporosis	0.0033	0.0033	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TLN1—osteoporosis	0.00329	0.00329	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—POMC—osteoporosis	0.0032	0.0032	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL6—osteoporosis	0.00319	0.00319	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CALCA—osteoporosis	0.00314	0.00314	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IL6—osteoporosis	0.00314	0.00314	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—TNF—osteoporosis	0.00311	0.00311	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—WNT1—osteoporosis	0.00311	0.00311	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PTHLH—osteoporosis	0.00309	0.00309	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TLN1—osteoporosis	0.00303	0.00303	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MGLL—osteoporosis	0.00303	0.00303	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—LRP5—osteoporosis	0.00296	0.00296	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—P4HB—osteoporosis	0.00283	0.00283	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—LRP6—osteoporosis	0.00283	0.00283	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PTHLH—osteoporosis	0.00281	0.00281	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PTH—osteoporosis	0.00276	0.00276	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CALCA—osteoporosis	0.00272	0.00272	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—RAP1A—osteoporosis	0.00271	0.00271	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CNR2—osteoporosis	0.00269	0.00269	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—ADCY5—osteoporosis	0.00267	0.00267	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NFATC1—osteoporosis	0.00264	0.00264	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—DKK1—osteoporosis	0.00262	0.00262	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—P4HB—osteoporosis	0.00261	0.00261	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PTH—osteoporosis	0.00254	0.00254	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—WNT1—osteoporosis	0.00253	0.00253	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—POMC—osteoporosis	0.00252	0.00252	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL6—osteoporosis	0.00251	0.00251	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—RAP1A—osteoporosis	0.0025	0.0025	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CNR2—osteoporosis	0.00248	0.00248	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CALCA—osteoporosis	0.00247	0.00247	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—ADCY5—osteoporosis	0.00246	0.00246	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—FGA—osteoporosis	0.00246	0.00246	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NFATC1—osteoporosis	0.00244	0.00244	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—ADCY5—osteoporosis	0.00242	0.00242	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—DKK1—osteoporosis	0.00242	0.00242	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TLN1—osteoporosis	0.00239	0.00239	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—WNT1—osteoporosis	0.00233	0.00233	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PTHLH—osteoporosis	0.00228	0.00228	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—BMP2—osteoporosis	0.00228	0.00228	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—FGA—osteoporosis	0.00227	0.00227	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—FGB—osteoporosis	0.00223	0.00223	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—ADCY5—osteoporosis	0.00223	0.00223	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PSMA2—osteoporosis	0.00216	0.00216	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PSMA5—osteoporosis	0.00216	0.00216	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PTHLH—osteoporosis	0.00211	0.00211	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—BMP2—osteoporosis	0.00211	0.00211	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—FGB—osteoporosis	0.00206	0.00206	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—P4HB—osteoporosis	0.00206	0.00206	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CALCA—osteoporosis	0.00201	0.00201	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PTH—osteoporosis	0.002	0.002	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PSMA2—osteoporosis	0.00199	0.00199	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PSMA5—osteoporosis	0.00199	0.00199	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—RAP1A—osteoporosis	0.00197	0.00197	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—POMC—osteoporosis	0.00196	0.00196	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CNR2—osteoporosis	0.00195	0.00195	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.00194	0.00194	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—ADCY5—osteoporosis	0.00194	0.00194	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NFATC1—osteoporosis	0.00192	0.00192	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—DKK1—osteoporosis	0.0019	0.0019	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CALCA—osteoporosis	0.00186	0.00186	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—WNT1—osteoporosis	0.00183	0.00183	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—KL—osteoporosis	0.00183	0.00183	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—POMC—osteoporosis	0.00181	0.00181	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—FGA—osteoporosis	0.00178	0.00178	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—POMC—osteoporosis	0.00178	0.00178	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—ADCY5—osteoporosis	0.00176	0.00176	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL6R—osteoporosis	0.00174	0.00174	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—KL—osteoporosis	0.00168	0.00168	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PTHLH—osteoporosis	0.00166	0.00166	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—BMP2—osteoporosis	0.00166	0.00166	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—POMC—osteoporosis	0.00164	0.00164	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—FGB—osteoporosis	0.00162	0.00162	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL6R—osteoporosis	0.0016	0.0016	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PSMA2—osteoporosis	0.00157	0.00157	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PSMA5—osteoporosis	0.00157	0.00157	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CALCA—osteoporosis	0.00146	0.00146	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ADCY5—osteoporosis	0.00143	0.00143	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—POMC—osteoporosis	0.00142	0.00142	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SPP1—osteoporosis	0.00138	0.00138	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—KL—osteoporosis	0.00133	0.00133	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ADCY5—osteoporosis	0.00132	0.00132	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—POMC—osteoporosis	0.00129	0.00129	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SPP1—osteoporosis	0.00128	0.00128	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL6R—osteoporosis	0.00126	0.00126	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IRS2—osteoporosis	0.00125	0.00125	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—LEP—osteoporosis	0.00122	0.00122	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ESR1—osteoporosis	0.00117	0.00117	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IRS2—osteoporosis	0.00115	0.00115	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—LEP—osteoporosis	0.00113	0.00113	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IRS1—osteoporosis	0.00109	0.00109	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ESR1—osteoporosis	0.00108	0.00108	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—POMC—osteoporosis	0.00105	0.00105	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ADCY5—osteoporosis	0.00104	0.00104	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL6R—osteoporosis	0.00103	0.00103	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IGF1—osteoporosis	0.00101	0.00101	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IRS1—osteoporosis	0.00101	0.00101	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SPP1—osteoporosis	0.00101	0.00101	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—POMC—osteoporosis	0.000971	0.000971	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL6R—osteoporosis	0.000947	0.000947	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IGF1—osteoporosis	0.000934	0.000934	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IRS2—osteoporosis	0.000909	0.000909	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—LEP—osteoporosis	0.00089	0.00089	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ESR1—osteoporosis	0.000849	0.000849	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IRS1—osteoporosis	0.000794	0.000794	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL6—osteoporosis	0.000774	0.000774	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—POMC—osteoporosis	0.000764	0.000764	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL6R—osteoporosis	0.000746	0.000746	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IGF1—osteoporosis	0.000735	0.000735	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL6—osteoporosis	0.000714	0.000714	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MYC—osteoporosis	0.000608	0.000608	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TGFB1—osteoporosis	0.000607	0.000607	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL6—osteoporosis	0.000562	0.000562	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MYC—osteoporosis	0.000561	0.000561	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TGFB1—osteoporosis	0.00056	0.00056	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL6—osteoporosis	0.000457	0.000457	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MYC—osteoporosis	0.000442	0.000442	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TGFB1—osteoporosis	0.000441	0.000441	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL6—osteoporosis	0.000422	0.000422	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL6—osteoporosis	0.000332	0.000332	CbGpPWpGaD
